论文部分内容阅读
大型生长激素(PRL)型垂体腺瘤是一种较为常见的激素分泌性垂体瘤[1],在此类型中所占的比重约为35%~45%[2],PRL垂体腺瘤种类中的侵袭性腺瘤具有全切率低、复发率高的特点[3],成为临床治疗的难点。但是经过医疗科学人员的不懈努力,终于研制出了对抗PRL垂体腺瘤的方式,但是在目前医疗技术水平条件的制约下,手术、放疗、药物等治疗措施仍很难将其彻底根治。经过体外实验研究
Large-sized growth hormone (PRL) type of pituitary adenoma is a more common hormone secreting pituitary tumor [1], in this type of share of about 35% to 45% [2], PRL pituitary adenoma species Of invasive adenoma with low total cut rate, high recurrence rate [3], has become a clinical treatment difficulties. However, after the unremitting efforts of the medical scientists, the way to fight PRL pituitary adenoma was finally developed. However, under the current medical technology and conditions, it is still difficult to completely cure such diseases as surgery, radiotherapy and drugs. After in vitro experimental study